1
|
Parreau S, Espitia O, Bold MS, Frota Lima LM, Lades G, Bois M, Assaraf M, Saadoun D, Koster MJ, Ly KH, Weyand CM, Warrington KJ, Liozon E. Relationship between histopathological features of non-infectious aortitis and the results of pre-operative 18F-FDG-PET/CT: a retrospective study of 16 patients. Clin Exp Rheumatol 2023; 41:916-921. [PMID: 36762741 DOI: 10.55563/clinexprheumatol/5mevq4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2022] [Accepted: 12/05/2022] [Indexed: 02/11/2023]
Abstract
OBJECTIVES To describe the characteristics of 18F-fluorodeoxyglucose positron-emission tomography/computed-tomography (18FDG-PET/CT) findings before surgery in patients with active, histologically confirmed aortitis, and to correlate the degree of arterial wall inflammation with PETVAS score. METHODS This was a multiple-centre retrospective study including cases with histologically proven active, non-infectious aortitis who had a 18FDG-PET/CT performed within one year before surgery for aneurysm repair. PETVAS score was determined by radiologists blinded to the pathology findings. Cardiovascular pathologists reviewed aortic tissue samples and graded the degree of inflammation in the vessel wall. RESULTS Sixteen patients were included (8 giant cell arteritis, 4 clinically isolated aortitis, 2 Takayasu's arteritis, 1 relapsing polychondritis, and 1 rheumatoid arthritis). In 5/16 (31%) patients, 18FDG-PET/CT did not detect the presence of aortic inflammation; two of whom were being treated with glucocorticoids at the time of procedure. Ascending thoracic and abdominal aorta had the highest FDG uptake among the affected territories. Patients without active aortitis on 18FDG-PET/CT were significantly older (p=0.027), had a lower PETVAS score (p=0.007), and had a lower degree of adventitial inflammation (p=0.035). In contrast, there was no difference between 18FDG-PET/CT active and inactive aortitis patients as regards the timing between PET/CT and surgery, serum CRP level (during 18FDG-PET/CT) and, FDG uptake per study site. CONCLUSIONS In histologically proved aortitis, 18FDG-PET/CT before surgery did not detect vascular inflammation in 31% patients, and PETVAS score correlated with the degree of adventitial histopathologic inflammation.
Collapse
Affiliation(s)
- Simon Parreau
- Division of Rheumatology, Mayo Clinic, Rochester, MN, USA, and Department of Internal Medicine, Dupuytren Hospital, Limoges, France.
| | - Olivier Espitia
- Nantes Université, CHU Nantes, Department of Internal and Vascular Medicine, Nantes, France
| | - Michael S Bold
- Department of Radiology, Mayo Clinic, Rochester, MN, USA
| | | | - Guillaume Lades
- Department of Nuclear Medicine, Dupuytren Hospital, Limoges, France
| | - Mélanie Bois
- Department of Pathology, Mayo Clinic, Rochester, MN, USA
| | - Morgane Assaraf
- AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, Paris, France
| | - David Saadoun
- AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, Paris, France
| | | | - Kim-Heang Ly
- Department of Internal Medicine, Dupuytren Hospital, Limoges, France
| | | | | | - Eric Liozon
- Department of Internal Medicine, Dupuytren Hospital, Limoges, France
| |
Collapse
|
2
|
Salvador B, Lades G, Parreau S, Dumonteil S, Brisset J, Jamilloux Y, Gerfaud-Valentin M, Hot A, Abraham J, Jaccard A, Gondran G, Liozon E, Fauchais A, Monteil J, Ly K. Comparaison de la tomographie par émission de positons entre maladie de Still et lymphome non hodgkinien. Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.10.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
3
|
Parreau S, Espitia O, Bold M, Frota Lima L, Lades G, Bois M, Assaraf M, Saadoun D, Koster M, Ly K, Weyand C, Warrington K, Liozon E. Aortites prouvées histologiquement et 18F-FDG-PET/CT réalisée avant chirurgie. Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.10.115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
4
|
Labonde A, Lades G, Debourdeau A, Ragi O, Lehmann L, Vitton V, Barthet M, Legros R, Albouys J, Geyl S, Loustaud-Ratti V, Monteil J, Gonzalez S, Gonzalez JM, Jacques J. Gastric peroral endoscopic myotomy in refractory gastroparesis: long-term outcomes and predictive score to improve patient selection. Gastrointest Endosc 2022; 96:500-508.e2. [PMID: 35413333 DOI: 10.1016/j.gie.2022.04.002] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/12/2021] [Accepted: 04/03/2022] [Indexed: 02/08/2023]
Abstract
BACKGROUND AND AIMS Limited data exist concerning the long-term efficiency of gastric peroral endoscopic myotomy (G-POEM) as a treatment of refractory gastroparesis. This study evaluated the 3-year results of G-POEM in patients with refractory gastroparesis. METHODS This was a prospective multicenter study of all G-POEM operations performed in 2 expert French centers for 46 patients with refractory gastroparesis with at least 3 years of follow-up. RESULTS Clinical success was 65.2% at 36 months. There was significant improvement in symptom severity. Median Gastroparesis Cardinal Symptom Index decreased from 3.33 to 1.80 (P < .0001), with improvement in all subscales. We created a predictive score concerning G-POEM success (G-POEM predictive score) to which points were assigned as follows: nausea subscale <2: predictive of success, 1 point; satiety subscale >4: predictive of success, 1 point; bloating subscale >3.5: predictive of success, 1 point; percentage of gastric retention at 4 hours on scintigraphy >50%: 1 point. A threshold of 2 was identified by receiver operating characteristic curve analysis with an area under the curve of .825 that predicted clinical success with a sensitivity of 93.3% (95% confidence interval [CI], .77-.99), specificity of 56.3% (95% CI, .33-.77), positive predictive value of 80% (95% CI, .67-.93), negative predictive value of 81.8% (95% CI, .59-1.00), and accuracy of 80.4% (95% CI, .69-.92). Patients with a score ≥2 were significantly more likely to be responders at 3 years than were patients with a score <2 (80% and 18%, respectively; P = .0004). CONCLUSIONS The clinical success of G-POEM for refractory gastroparesis was 65.2% at 36 months. Our predictive score offers an easy tool that needs to be confirmed in other studies.
Collapse
Affiliation(s)
- Amélie Labonde
- Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France
| | | | - Antoine Debourdeau
- Service d'Hépato-gastro-entérologie, CHU Montpellier, Montpellier, France
| | - Olivier Ragi
- Service d'Hépato-gastro-entérologie, CHU Lyon, Lyon, France
| | - Lauriane Lehmann
- Service d'Hépato-gastro-entérologie, Polyclinique de Limoges, Limoges, France
| | - Véronique Vitton
- Service d'Hépato-gastro-entérologie, APHM Hôpital Nord, Marseille, France
| | - Marc Barthet
- Service d'Hépato-gastro-entérologie, APHM Hôpital Nord, Marseille, France
| | - Romain Legros
- Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France
| | - Jérémie Albouys
- Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France
| | - Sophie Geyl
- Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France
| | | | - Jacques Monteil
- Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France
| | - Sandra Gonzalez
- Service de médecine nucléaire, APHM Hôpital Nord, Marseille, France
| | | | - Jérémie Jacques
- Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France.
| |
Collapse
|
5
|
Lades G, Carpenet H, Benoit U, Aboyans V, Monteil J. Tc-99m HMDP bone scintigraphy for cardiac amyloidosis diagnosis: A false positive case. J Nucl Cardiol 2022; 29:2051-2052. [PMID: 33389639 DOI: 10.1007/s12350-020-02451-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2020] [Accepted: 11/16/2020] [Indexed: 11/26/2022]
Abstract
A 68-year-old man with heart failure (left ventricular ejection fraction = 30%) and normal coronary angiography underwent bone scintigraphy for suspected transthyretin-related cardiac amyloidosis (CA).1 He received 532 MBq (14.3 mCi) Tc-99m hydroxy-methyl-diphosphonate (HMDP) and data were acquired 2 hours after injection. On anterior and posterior whole-body scans (Figure 1 A and B), diffuse cardiac, hepatic, and soft-tissue uptake of the radiotracer was seen, in association with low skeletal uptake. It was established that the patient had recently been hospitalized for heart failure exacerbation and had received an intravenous iron injection, which is a recommended treatment for heart failure.2 In consultation with our hospital's cardiology team, it was decided to repeat the bone scan at a time when the patient had received no recent iron infusion. Two months after the first bone scan, the patient received 556 MBq (15 mCi) of 99m-Tc HMDP, and no cardiac, hepatic, or soft-tissue uptake was detected (Figure 1C and D).
Collapse
Affiliation(s)
- Guillaume Lades
- Department of Nuclear Medicine, CHU Dupuytren, 2 rue Martin Luther King, 87000, Limoges, France.
| | - Hélène Carpenet
- Department of Nuclear Medicine, CHU Dupuytren, 2 rue Martin Luther King, 87000, Limoges, France
| | - Unvoy Benoit
- Department of Nuclear Medicine, CHU Dupuytren, 2 rue Martin Luther King, 87000, Limoges, France
| | - Victor Aboyans
- Department of Cardiology, Université de Limoges, Limoges, France
| | - Jacques Monteil
- Department of Nuclear Medicine, CHU Dupuytren, 2 rue Martin Luther King, 87000, Limoges, France
| |
Collapse
|
6
|
Monteil J, Le Brun-Ly V, Cachin F, Zasadny X, Seitz JF, Mundler O, Selvy M, Smith D, Rullier E, Lavau-Denes S, Lades G, Labrunie A, Lecaille C, Valli N, Leobon S, Terrebonne E, Deluche E, Tubiana-Mathieu N. Comparison of 18FDG-PET/CT and conventional follow-up methods in colorectal cancer: A randomised prospective study. Dig Liver Dis 2021; 53:231-237. [PMID: 33153929 DOI: 10.1016/j.dld.2020.10.012] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/03/2020] [Revised: 10/02/2020] [Accepted: 10/06/2020] [Indexed: 12/11/2022]
Abstract
BACKGROUND A surveillance program was performed in colorectal cancer (CRC) patients after surgery, to diagnose asymptomatic recurrence. AIMS To assess whether 18-FDG positron emission tomography/CT (PET/CT) improved the detection of recurrence during a 3-year follow-up. METHODS A multicentre, two-arm randomised prospective trial comparing different 36-month follow-up strategies. Complete colonoscopy was performed at baseline and after 3 years and clinical exams with imaging every 3 months. The conventional arm (A) received carcinoembryonic antigen, liver echography, and alternated between lung radiography and computed tomography (CT) scans. The experimental arm (B) received PET/CT. RESULTS A total of 365 patients with colon (79.4%) or rectal cancer (20.6%), stages II (48.2%) or III (50.8%), were enroled in this study. At 36 months, intention-to-treat analysis revealed recurrence in 31 (17.2%) patients in arm A and 47 (25.4%) in arm B (p = 0.063). At 3 years, 7 of 31 relapses (22.5%) in arm A were surgically treated with curative intent, compared to 17 of 47 (36.2%) in arm B (p = 0.25). The rates of recurrence and new cancers were higher in arm B than arm A (p = 0.038). CONCLUSIONS PET/CT follow-up every 6 months did not increase the rate of recurrence at 3 years or the rate of surgically treated recurrence compared with conventional follow-up.
Collapse
Affiliation(s)
- Jacques Monteil
- Department of Nuclear Medicine, University Hospital, Limoges, France
| | | | - Florent Cachin
- Department of Nuclear Medicine, Jean Perrin Cancer Institute, Clermont-Ferrand, France
| | - Xavier Zasadny
- Department of Radiotherapy, François Chénieux Clinic, Limoges, France
| | - Jean-François Seitz
- Department of Oncology and Hepato-Gastroenterology, University Hospital La Timone, Marseille, France
| | - Olivier Mundler
- Department of Nuclear Medicine, University Hospital La Timone, Marseille, France
| | - Marie Selvy
- Department of Digestive Surgery and Oncology, Estaing Hospital, Clermont-Ferrand, France
| | - Denis Smith
- Department of Digestive Oncology, University Hospital Saint André, Bordeaux, France
| | - Eric Rullier
- Department of Digestive Surgery, University Hospital Saint André, Bordeaux, France
| | | | - Guillaume Lades
- Department of Nuclear Medicine, University Hospital, Limoges, France
| | - Anais Labrunie
- Department of Biostatistics and Clinical Research, University Hospital, Limoges, France
| | - Cedric Lecaille
- Department of Gastroenterology and Digestive Oncology, Bordeaux Nord Polyclinic, Bordeaux, France
| | - Nathalie Valli
- Department of Nuclear Medicine, Bordeaux Nord Polyclinic, Bordeaux, France
| | - Sophie Leobon
- Department of Medical Oncology, University Hospital, Limoges, France
| | - Eric Terrebonne
- Department of Gastroenterology and Digestive Oncology, University Hospital Haut-Lévêque, Bordeaux, France
| | - Elise Deluche
- Department of Medical Oncology, University Hospital, Limoges, France.
| | | |
Collapse
|
7
|
Lades G, Carpenet H, Magne J, Gondran G, Guyot A, Abraham J, El Badaoui-Oubrahim A, Verbeke S, Jaccard A, Ly K, Monteil J. La TEP-TDM au 18-FDG est-elle un outil fiable pour différencier sarcoïdose et lymphome dans les cas de polyadénopathies ? Rev Med Interne 2020. [DOI: 10.1016/j.revmed.2020.10.131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
8
|
Brisset J, Jamilloux Y, Lades G, Killian M, Gerfaud-Valentin M, Lemaire A, Chroboczek T, Liozon E, Gondran G, Monteil J, Ly K. Intérêts du 18F-FDG PET/CT dans la prise en charge de la maladie de Still de l’adulte : à propos de 35 cas. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.10.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|